Company news
RenovoRx, Inc. news in 2022
RenovoRx, Inc.'s news releases, calls and decks from 2022, newest first.
RenovoRx Announces Acceptance of Four Clinical Data Abstracts at the 2023 ASCO Gastrointestinal Cancers (ASCO GI) Symposium
December 14, 2022
RenovoRx Announces Presentations at the Advanced Interventional Management Symposium (AIMsymposium) Highlighting its Innovative RenovoTAMP® Therapy Platform for Targeted Treatment of Cancers
November 16, 2022
RenovoRx Reports Third Quarter 2022 Financial Results
November 13, 2022
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology (CIO) Highlighting its Innovative Therapy Platform for Targeted Treatment of Pancreatic Cancer
September 27, 2022
RenovoRx Appoints Angela Gill Nelms as Chief Operating Officer
September 18, 2022
RenovoRx Reports Second Quarter 2022 Financial Results
August 14, 2022
RenovoRx Appoints James Ahlers as Chief Financial Officer
July 18, 2022
RenovoRx Reports First Quarter 2022 Financial Results
May 15, 2022
RenovoRx Reports Full Year 2021 Financial Results
March 29, 2022
RenovoRx Announces Presentation at the 2022 SPECTRUM Conference Highlighting Its Innovative RenovoTAMP™ Therapy for Targeted Treatment of Cancer
January 18, 2022